HIV Citation List: July 22, 2011 - August 4, 2011
Pubmed citations
1. Design of HIV-1 Protease Inhibitors with C3-Substituted Hexahydrocyclopentafuranyl Urethanes as P2-Ligands: Synthesis, Biological Evaluation, and Protein-Ligand X-ray Crystal Structure. Ghosh, A.K., B.D. Chapsal, G.L. Parham, M. Steffey, J. Agniswamy, Y.F. Wang, M. Amano, I.T. Weber, and H. Mitsuya, Journal of Medicinal Chemistry, 2011. [Epub ahead of print]; PMID[21800876].
[PubMed]. HIV_0722-080411.
2. Comparative Docking and CoMFA Analysis of Curcumine Derivatives as HIV-1 Integrase Inhibitors. Gupta, P., P. Garg, and N. Roy, Molecular Diversity, 2011. 15(3): p. 733-750; PMID[21327540].
[PubMed]. HIV_0722-080411.
3. Identification of Low-Molecular Weight Inhibitors of HIV-1 Reverse Transcriptase using a Cell-based High-throughput Screening System. Jegede, O., A. Khodyakova, M. Chernov, J. Weber, L. Menendez-Arias, A. Gudkov, and M.E. Quinones-Mateu, Antiviral Research, 2011. 91(2): p. 94-98; PMID[21600931].
[PubMed]. HIV_0722-080411.
4. Designed Oligomers of Cyanovirin-N Show Enhanced HIV Neutralization. Keeffe, J.R., P.N. Gnanapragasam, S.K. Gillespie, J. Yong, P.J. Bjorkman, and S.L. Mayo, Proceedings of the National Academy of Sciences of the United States of America, 2011. [Epub ahead of print]; PMID[21799112].
[PubMed]. HIV_0722-080411.
5. Rational Design of Peptides with Anti-HCV/HIV Activities and Enhanced Specificity. Li, G.R., L.Y. He, X.Y. Liu, A.P. Liu, Y.B. Huang, C. Qiu, X.Y. Zhang, J.Q. Xu, W. Yang, and Y.X. Chen, Chemical Biology and Drug Design, 2011. [Epub ahead of print]; PMID[21801309].
[PubMed]. HIV_0722-080411.
6. Anti-HIV Siamycin I Directly Inhibits Autophosphorylation Activity of the Bacterial FsrC Quorum Sensor and other ATP-dependent Enzyme Activities. Ma, P., K. Nishiguchi, H.M. Yuille, L.M. Davis, J. Nakayama, and M.K. Phillips-Jones, FEBS Letters, 2011. [Epub ahead of print]; PMID[21803040].
[PubMed]. HIV_0722-080411.
7. Synthesis and Biological Activity of Naphthyl-substituted (B-ring) benzophenone Derivatives as Novel Non-Nucleoside HIV-1 Reverse Transcriptase Inhibitors. Ma, X.D., X. Zhang, H.F. Dai, S.Q. Yang, L.M. Yang, S.X. Gu, Y.T. Zheng, Q.Q. He, and F.E. Chen, Bioorganic & Medicinal Chemistry, 2011. 19(15): p. 4601-4607; PMID[21719299].
[PubMed]. HIV_0722-080411.
8. Toward the Discovery of Novel Anti-HIV Drugs. Second-Generation Inhibitors of the Cellular ATPase DDX3 with Improved Anti-HIV Activity: Synthesis, Structure-Activity Relationship Analysis, Cytotoxicity Studies, and Target Validation. Maga, G., F. Falchi, M. Radi, L. Botta, G. Casaluce, M. Bernardini, H. Irannejad, F. Manetti, A. Garbelli, A. Samuele, S. Zanoli, J.A. Este, E. Gonzalez, E. Zucca, S. Paolucci, F. Baldanti, J. De Rijck, Z. Debyser, and M. Botta, ChemMedChem, 2011. 6(8): p. 1371-1389; PMID[21698775].
[PubMed]. HIV_0722-080411.
9. Celastrol Inhibits Tat-Mediated Human Immunodeficiency Virus (HIV) Transcription and Replication. Narayan, V., K.C. Ravindra, C. Chiaro, D. Cary, B.B. Aggarwal, A.J. Henderson, and K.S. Prabhu, Journal of Molecular Biology, 2011. 410(5): p. 972-983; PMID[21763500].
[PubMed]. HIV_0722-080411.
10. New First and Second Generation Inhibitors of Human Immunodeficiency Virus-1 Integrase. Pendri, A., N.A. Meanwell, K.M. Peese, and M.A. Walker, Expert Opinion on Therapeutic Patents, 2011. 21(8): p. 1173-1189; PMID[21599420].
[PubMed]. HIV_0722-080411.
11. Abacavir and Lamivudine for the Treatment of Human Immunodeficiency Virus. Rizzardini, G. and P. Zucchi, Expert Opinion on Pharmacotherapry, 2011. [Epub ahead of print]; PMID[21787242].
[PubMed]. HIV_0722-080411.
12. Analysis of HIV-1 Fusion peptide Inhibition by Synthetic Peptides from E1 Protein of GB Virus C. Sanchez-Martin, M.J., K. Hristova, M. Pujol, M.J. Gomara, I. Haro, M.A. Alsina, and M.A. Busquets, Journal of Colloid and Interface Science, 2011. 360(1): p. 124-131; PMID[21565353].
[PubMed]. HIV_0722-080411.
13. Synthesis and Antiviral Evaluation of 9-(S)-[3-Alkoxy-2-(phosphonomethoxy)propyl]nucleoside alkoxyalkyl esters: Inhibitors of Hepatitis C Virus and HIV-1 Replication. Valiaeva, N., D.L. Wyles, R.T. Schooley, J.B. Hwu, J.R. Beadle, M.N. Prichard, and K.Y. Hostetler, Bioorganic & Medicinal Chemistry, 2011. 19(15): p. 4616-4625; PMID[21719300].
[PubMed]. HIV_0722-080411.
ISI Web of Knowledge citations
14. Isolation, Identification and Antiviral Activities of Metabolites of Calycosin-7-O-beta-D-glucopyranoside. Chen, L.Y., Z.X. Li, Y.H. Tang, X.L. Cui, R.H. Luo, S.S. Guo, Y.T. Zheng, and C.G. Huang, Journal of Pharmaceutical and Biomedical Analysis, 2011. 56(2): p. 382-389; ISI[000292785900028].
[WOS]. HIV_0722-080411.
15. Synthesis of a Labeled Inhibitor of HIV-1 Attachment: 1-(4-Benzoylpiperazin-1-yl)-2-(4,7-dimethoxy-1H-pyrrolo[2,3-c]pyridinyl- 3-yl-[U-(14)C]ethane-1,2-dione, BMS-488043-(14)C. Ekhato, I.V. and J.K. Rinehart, Journal of Labelled Compounds & Radiopharmaceuticals, 2011. 54(6): p. 289-291; PMID[000292571200001].
[WOS]. HIV_0722-080411.
16. Homogeneous Enzyme Immunoassay for HIV-1 Antiretroviral Drugs: Darunavir and Maraviroc. Kasper, K.C., B. Moon, J. Nguyen, A. Orozco, K. Chung, J. Valencia, and J. Valdez, Therapeutic Drug Monitoring, 2011. 33(4): p. 519-519; ISI[000292761500211].
[WOS]. HIV_0722-080411.
17. Novel PI3K/Akt Inhibitors Screened by the Cytoprotective Function of Human Immunodeficiency Virus Type 1 Tat. Kim, Y., J.A. Hollenbaugh, D.H. Kim, and B. Kim, Plos One, 2011. 6(7); ISI[000292699000011].
[WOS]. HIV_0722-080411.
18. New Substituted Thiazol-2-ylidene-benzamides and Their Reaction with 1-Aza-2-azoniaallene Salts. Saeed, A., N.A. Al-Masoudi, A.A. Ahmed, and C. Pannecouque, Synthesis and anti-HIV Activity. Zeitschrift Fur Naturforschung Section B-a Journal of Chemical Sciences, 2011. 66(5): p. 512-520; ISI[000292795600012].
[WOS]. HIV_0722-080411.
19. Synthesis of 3-Guaninyl- and 3-Adeninyl-5-hydroxymethyl-2-pyrrolidinone nucleosides. Saleh, A., J.G. D'Angelo, M.D. Morton, J. Quinn, K. Redden, R.W. Mielguz, C. Pavlik, and M.B. Smith, Journal of Organic Chemistry, 2011. 76(14): p. 5574-5583; ISI[000292480300007].
[WOS]. HIV_0722-080411.
20. Effects of Cathelicidin and its Fragments on Three Key Enzymes of HIV-1. Wong, J.H., A. Legowska, K. Rolka, T.B. Ng, M. Hui, C.H. Cho, W.W.L. Lam, S.W.N. Au, O.W. Gu, and D.C.C. Wan, Peptides, 2011. 32(6): p. 1117-1122; ISI[000292586200004].
[WOS]. HIV_0722-080411.
21. Modeling and Hybrid Virtual Screening for the Discovery of Novel I kappa B Kinase 2 (IKK2) Inhibitors. Xie, H.Z., L.Y. Liu, J.X. Ren, J.P. Zhou, R.L. Zheng, L.L. Li, and S.Y. Yang, Pharmacophore Journal of Biomolecular Structure & Dynamics, 2011. 29(1): p. 165-179; ISI[000292531900010].
[WOS]. HIV_0722-080411.
22. Phosphonoformic Acid Inhibits Viral Replication by Trapping the Closed Form of the DNA Polymerase. Zahn, K.E., E.P. Tchesnokov, M. Gotte, and S. Doublie, Journal of Biological Chemistry, 2011. 286(28): p. 25246-25255; ISI[000292547900070].
[WOS]. HIV_0722-080411.
Patent citations
23. Preparation of β-Hairpin Peptidomimetics as CXCR4 Antagonists for Treatment of HIV and Other Diseases. Barthelemy, S., C. Bisang, F.O. Gombert, A. Lederer, D. Obrecht, B. Romagnoli, J. Zumbrunn, T. Remus, and G. Lemercier. Patent. 2011. 2009-EP66462 2011066869.
[Patent]. HIV_0722-080411.
24. Preparation of New Derivatives of 1,4,2-Benzodithiazine. Brzozowski, Z., F. Saczewski, and N. Neamati. Patent. 2011. 2005-377955 208177.
[Patent]. HIV_0722-080411.
25. Betulinic acid Derivatives as anti-HIV Agents. Chen, C.H., L. Huang, and K.-H. Lee. Patent. 2011. 2007-943956 20110152229.
[Patent]. HIV_0722-080411.
26. Preparation of 2,3,4,5-Tetrahydrobenzo[f][1,2]thiazepine Derivatives as Human Immunodeficiency Virus Protease Inhibitors. Ganguly, A.K., D. Biswas, S.S. Alluri, D. Caroccia, C.-H. Wang, and E.H. Kang. Patent. 2011. 2009-615903 20110112068.
[Patent]. HIV_0722-080411.
27. Preparation of Heterocycles as Antiviral Agents. Ma, J., F. Zhang, and J. Nie. Patent. 2011. 2011-10023093 102060786.
[Patent]. HIV_0722-080411.
28. Novel Carboxamide Derivatives as HIV Inhibitors and Their Preparation and Use in the Treatment of Viral Mediated Diseases. Parthasaradhi Reddy, B., B. Vamsi Krishna, V. Manohar Sharma, K. Rathnakar Reddy, M. Madhanmohan Reddy, L. Vl Subrahmanyam, and M. Prem Kumar. Patent. 2011. 2010-IB2907 2011061590.
[Patent]. HIV_0722-080411.
29. Preparation of Pyrimidine Derivatives as HIV Inhibitors. Shipps, G.W., Jr., C.C. Cheng, R.J. Herr, and J. Yang. Patent. 2011. 2010-US56767
2011060395.
[Patent]. HIV_0722-080411.
30. Sodium-Potassium Pump α1 Subunit-derived Peptides and their Derivatives Inhibiting Extracellular Release of HIV-1 Tat Protein and HIV-1 Replication. Agostini, S. and M. Giacca. Patent. 2011. 2010-IB55715 2011070533.
[Patent]. HIV_0722-080411.
31. Virus Receptor Fusion Proteins for Inhibition of Viral Entry into Target Cells. Bahrami, S., M. Tolstrup, M.D. Ryttergmrd, F.S. Pedersen, and L.J. Ostergaard. Patent. 2011. 2010-GB2321 2011077093.
[Patent]. HIV_0722-080411.
32. Novel Antiviral Compounds. Carlens, G., P. Chaltin, F. Christ, Z. Debyser, A. Marchand, D. Marchand, A. Voet, and M. De Maeyer. Patent. 2011. 2010-EP70306 2011076765.
[Patent]. HIV_0722-080411.
33. Preparation of Peptide Isosteres, Derivatives of 5-Amino-4-hydroxypentanoylamides, as HIV Protease Inhibitors. Kalayanov, G., B.R.R. Kesteleyn, K. Parkes, B.B. Samuelsson, W.B.G. Schepens, J.W.J. Thuring, H.K. Wallberg, and J.K. Wegner. Patent. 2011. 2010-EP69328 2011070131.
[Patent]. HIV_0722-080411.
34. Preparation of AZA-Peptides Containing 2,2-Disubstituted Cyclobutyl and/or Substituted Alkoxybenzyl Derivatives as Antivirals. Parthasaradhi Reddy, B., B. Vamsi Krishna, V. Manohar Sharma, K. Rathnakar Reddy, and M. Madhanmohan Reddy. Patent. 2011. 2010-IB3313 2011080562.
[Patent]. HIV_0722-080411.
35. Pharmaceutical use of Multicyclic Compounds as anti-AIDS Agents. Pianowski, L.F., J.B. Calixto, and C.P. Chaves. Patent. 2011. 2010-IB50198 2011086423.
[Patent]. HIV_0722-080411.
36. Preparation of 3'-Deoxy-3'-methylidene-β-L-nucleosides as Antiviral Agents. Zhou, X.X., S. Torssell, O. Wallner, and P. Sun. Patent. 2011. 2010-SE51374 2011075052.
[Patent]. HIV_0722-080411.